• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗凝血酶III日内瓦型:一种遗传性异常抗凝血酶III,其肝素辅助因子活性存在缺陷。

Antithrombin III Geneva: a hereditary abnormal AT III with defective heparin cofactor activity.

作者信息

de Moerloose P A, Reber G, Vernet P, Minazio P, Bouvier C A

出版信息

Thromb Haemost. 1987 Apr 7;57(2):154-7.

PMID:3603409
Abstract

A 43-year-old man presented a pulmonary embolism. The unusual circumstances of apparition, the age and the increased heparin requirements suggested an antithrombin III (AT III) deficiency. AT III activity was low in the propositus and seven other members of his family (mean 55%), but immunologic levels were normal (mean 110%). Crossed immunoelectrophoresis in absence of heparin showed a normal pattern, but in presence of heparin showed an abnormal peak as compared with controls. Kinetics experiments showed a normal inhibition of thrombin and Xa in absence of heparin, but abnormal in presence of heparin. Affinity chromatography on heparin-Sepharose revealed two populations of AT III, one of which was devoid of heparin cofactor activity. The toponym AT III Geneva is proposed for this new familial abnormal AT III with defective heparin cofactor activity.

摘要

一名43岁男性出现肺栓塞。其发病的特殊情况、年龄以及对肝素需求的增加提示抗凝血酶III(AT III)缺乏。先证者及其家族中其他7名成员的AT III活性较低(平均55%),但免疫水平正常(平均110%)。在无肝素情况下进行的交叉免疫电泳显示模式正常,但在有肝素情况下与对照组相比出现异常峰。动力学实验表明,在无肝素情况下对凝血酶和Xa的抑制正常,但在有肝素情况下异常。肝素-琼脂糖亲和层析显示有两种AT III群体,其中一种缺乏肝素辅因子活性。对于这种具有缺陷肝素辅因子活性的新型家族性异常AT III,建议命名为AT III日内瓦型。

相似文献

1
Antithrombin III Geneva: a hereditary abnormal AT III with defective heparin cofactor activity.抗凝血酶III日内瓦型:一种遗传性异常抗凝血酶III,其肝素辅助因子活性存在缺陷。
Thromb Haemost. 1987 Apr 7;57(2):154-7.
2
Homozygous variant of antithrombin III that lacks affinity for heparin, AT III Kumamoto.抗凝血酶III的纯合变体,对肝素缺乏亲和力,即熊本抗凝血酶III。
Thromb Haemost. 1989 Feb 28;61(1):20-4.
3
Homozygous variant of antithrombin III: AT III Fontainebleau.
Thromb Haemost. 1986 Aug 20;56(1):18-22.
4
Reactivity of a hereditary abnormal antithrombin III fraction in the inhibition of thrombin and factor Xa.遗传性异常抗凝血酶III组分对凝血酶和因子Xa的抑制反应性。
Thromb Haemost. 1980 Oct 31;44(2):92-5.
5
Antithrombin III Alger: a new homozygous AT III variant.
Thromb Haemost. 1986 Apr 30;55(2):218-21.
6
Characterization of an abnormal antithrombin (Milano 2) with defective thrombin binding.
Thromb Haemost. 1986 Dec 15;56(3):349-52.
7
Antithrombin III "Northwick Park": a variant antithrombin with normal affinity for heparin but reduced heparin cofactor activity.
Thromb Haemost. 1985 Jun 24;53(3):314-9.
8
Purification and characterization of hereditary abnormal antithrombin III with impaired thrombin binding.凝血酶结合受损的遗传性异常抗凝血酶III的纯化与特性分析
J Lab Clin Med. 1984 Aug;104(2):245-56.
9
Antithrombin III Avranches, a new variant with defective serine-protease inhibition--comparison with antithrombin III Charleville.抗凝血酶III阿弗朗什,一种具有缺陷性丝氨酸蛋白酶抑制功能的新变体——与抗凝血酶III沙勒维尔的比较。
Thromb Haemost. 1988 Aug 30;60(1):94-6.
10
Homozygous or compound heterozygous qualitative antithrombin III deficiency.纯合子或复合杂合子性抗凝血酶III定性缺乏症。
Nouv Rev Fr Hematol (1978). 1994 Aug;36(4):335-7.

引用本文的文献

1
Proposed heparin binding site in antithrombin based on arginine 47. A new variant Rouen-II, 47 Arg to Ser.基于精氨酸47提出的抗凝血酶中的肝素结合位点。一种新的变体鲁昂-II,47位精氨酸突变为丝氨酸。
J Clin Invest. 1988 Apr;81(4):1292-6. doi: 10.1172/JCI113447.